Negative Impact of Vapes on Public Health: WHO Calls for Urgent Action

Regulations by 2FIRSTS.ai
Dec.22.2023
Negative Impact of Vapes on Public Health: WHO Calls for Urgent Action
World Health Organization (WHO) states that there is no evidence that e-cigarettes effectively help smokers quit. Instead, evidence shows negative impacts on public health.

The World Health Organization (WHO) categorically states that there is no evidence to suggest that e-cigarettes can effectively assist community smokers in quitting smoking. On the contrary, there is existing evidence that indicates e-cigarettes have a negative impact on public health.

 

E-cigarettes have been widely available on the market and extensively promoted among young people. Currently, 34 countries have implemented bans on the sales of e-cigarettes, while 88 countries lack any minimum age restrictions for purchasing e-cigarettes. Additionally, 74 countries have no regulations in place regarding these harmful products.

 

World Health Organization Director-General Tedros Adhanom Ghebreyesus emphasized that "children are being lured into smoking and may become addicted to nicotine at a young age. I urge countries to implement strict measures to prevent the use of e-cigarettes in order to protect their citizens, especially children and adolescents.

 

E-cigarettes, which contain highly addictive nicotine, are harmful to health. While we have not yet fully understood their long-term effects on health, it has been established that they produce harmful substances, some of which are considered carcinogens, while others increase the risk of heart and lung diseases. The use of e-cigarettes may also affect brain development, leading to learning and cognitive impairments in young people. Pregnant women exposed to e-cigarettes may have adverse effects on the development of the fetus. The toxic gases in e-cigarettes also pose risks to those around the users.

 

The usage of e-cigarettes among children aged 13-15 is reported in all regions of the World Health Organization. In Canada, the prevalence of e-cigarette use among individuals aged 16-19 has doubled between 2017 and 2022. Similarly, in the UK, the number of teenagers using e-cigarettes has tripled in the past three years.

 

Research consistently indicates that even brief exposure to social media content about e-cigarettes can potentially increase both the willingness to use these products and the positive attitude towards e-cigarettes. Young people who use e-cigarettes are nearly three times more likely to use traditional cigarettes in the future.

 

The World Health Organization (WHO) has called on countries to take urgent measures to prevent the use of e-cigarettes and nicotine addiction, as well as to implement comprehensive tobacco control methods that align with each country's respective circumstances. In countries where the sale of e-cigarettes is prohibited, the WHO urges stronger enforcement of such bans and continuous monitoring to support public health interventions and ensure strict compliance. In countries where the sale of e-cigarettes as consumer products (including sales, imports, distribution, and production) is permitted, the WHO emphasizes the need for strict regulations to reduce their attractiveness and harm to the public. This includes the prohibition of all flavors, limitations on nicotine concentration and content, as well as taxation.

 

The strategy for smoking cessation should be based on the best available evidence and should be accompanied by other tobacco control measures, and it should be monitored and evaluated. According to the current evidence, the government should not allow the sales of e-cigarettes as consumer products in order to achieve the goal of smoking cessation.

 

Any government that adopts an e-cigarette smoking cessation strategy must regulate the conditions of product exposure to ensure proper clinical conditions and manage drug products (including requiring them to be distributed as pharmaceuticals). Even in such strict forms, the decision to pursue e-cigarettes as a means to achieve smoking cessation goals should only be made after reviewing domestic conditions, as well as examining smoking risks and proven cessation strategies.

 

Due to the growing prevalence of e-cigarette use, which has been found to have harmful effects on the health of children and adolescents, decisive action must be taken to prevent the use of e-cigarettes.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Philip Morris International (PMI) has launched ZYN Melts in the UK, introducing a fully dissolvable oral nicotine tablet format alongside the brand's existing nicotine pouches. The range includes Cool Mint and Peppermint, each offered at 1mg and 2mg of nicotine per tablet, creating four SKUs. Each can contains 20 tablets and is priced at £6.50 in the UK. Unlike ZYN nicotine pouches, Melts are placed between the upper lip and gum and dissolve completely during use.
News
Sep.29 by 2Firsts Perspectives
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives
Special Report|Virginia Vape Directory Shows Contrast Between Vuse and JUUL Pod Systems and CrossBar 20K, Loon Flavored Disposables
Special Report|Virginia Vape Directory Shows Contrast Between Vuse and JUUL Pod Systems and CrossBar 20K, Loon Flavored Disposables
A 2Firsts analysis of Virginia's liquid nicotine and vapor product certification directory identified 213 product records from 15 manufacturers. Companies associated with BAT, Altria, Imperial Brands, JTI and JUUL account for 127 entries. The directory also includes independent brands CrossBar 20K, Loon and Breeze. CrossBar advertises a 13mL disposable capable of up to 20,000 puffs, while Loon has 16 disposable entries featuring fruit, cooling and beverage-related flavors. Of all records, 120 are labeled as under FDA PMTA review. Virginia introduced revised penalties on October 1, 2026, including a minimum first-violation civil penalty of $5,000 per unlisted product, alongside new retail tobacco permitting requirements.
Regulations
Oct.30
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
The U.S. Food and Drug Administration (FDA) has named Jessica Zeller director of the Center for Tobacco Products' (CTP) Office of Compliance and Enforcement (OCE), effective November 1, 2026. Zeller, the office's inaugural deputy director, returns from medical device manufacturer Edwards Lifesciences with more than 20 years of regulatory and legal experience. The appointment follows CTP leadership changes and adjustments to tobacco regulation. Bret Koplow became permanent CTP director in September; the FDA revised enforcement priorities for unauthorized e-cigarettes and nicotine pouches in May and announced faster PMTA review procedures. On September 28, the agency said it would evaluate changes to the existing PMTA regulatory framework, including potential rulemaking to replace it.
FDA
Oct.20 by 2Firsts Perspectives
Beyond IQOS ILUMA, PMI Expands Lower-Priced BONDS Heated Tobacco Platform: Seven Markets Added in Q3, With Rollouts in Japan, Europe and North Africa
Beyond IQOS ILUMA, PMI Expands Lower-Priced BONDS Heated Tobacco Platform: Seven Markets Added in Q3, With Rollouts in Japan, Europe and North Africa
Philip Morris International (PMI) is expanding the international footprint of BONDS by IQOS, its lower-priced heated tobacco platform. The company's third-quarter 2026 SEC filing shows that BONDS devices and BLENDS tobacco sticks were available in 15 markets at the end of September, up from eight at the end of June. In November, PMI announced plans to extend sales from three to 17 Japanese prefectures and introduced BONDS in Spain and Morocco. The platform uses ROUNDHEAT external heating technology and proprietary tobacco sticks, separate from the IQOS ILUMA system. In Japan, BONDS retails for ¥2,980, approximately 25% below ILUMA i ONE, while BLENDS costs ¥570 per pack. PMI management says BONDS targets cigarette smokers who have not adopted heated tobacco. Separate sales and revenue figures remain undisclosed.
company
Nov.06